We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Shedding Light on How Tumors Become Resistant to Immunotherapy

News   Jul 26, 2017 | Original story from University of Zurich

 
Shedding Light on How Tumors Become Resistant to Immunotherapy

The epigenetic control protein Ezh2 plays a central role in how cancer cells develop resistance. (Bild: D. Zingg, UZH)

 
 
 

RELATED ARTICLES

Ebola Vaccine Could Stretch Farther

News

A new study has identified that a single dose of a highly diluted Ebola vaccine still fully protected against disease in a monkey model.

READ MORE

Ranitidine Recalled Due to Potential Carcinogen Contamination

News

Teva UK Ltd is recalling unexpired stock of certain batches of two types of Ranitidine medicines – used to treat conditions such as heartburn and stomach ulcers.

READ MORE

International Alliance Aims To Detect the (Almost) Undetectable

News

A new transatlantic research alliance aims to develop radical new strategies and technologies to detect cancer at its earliest stage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE